Bibliometric analysis of research trends and hotspots in immunotherapy biomarkers for non-small cell lung cancer from 2015 to 2024

Key Points

• Identifying significant trends in immunotherapy biomarkers for lung cancer enhances understanding of treatment options, leading to potential breakthroughs.
• Between 2015 and 2024, 85% of publications focus on novel biomarkers related to immunotherapy in non-small cell lung cancer.
• Bibliometric analysis highlights growing interest in specific immunotherapy biomarkers, emphasizing areas for further investigation and development.
• Highlighting research hotspots aids in directing future studies towards impactful discoveries, fostering advancements in lung cancer treatment.